Communication suite à la séance du 31 mai 2011 "Optimiser la reprise fonctionnelle d'un greffon en attente de transplantation" - 21 pagesNational audienceThere is a shortage of heart donors. Some available organs are lost through deterioration prior to transplantation. Indeed, from the moment of brain death until reperfusion in the recipient, cardiac grafts (and also kidney, lung and liver grafts) can undergo irreversible damage due to cardioplegia, the harvesting procedure, and hypothermic transport. The noxious phenomena occurring during cold ischaemia and myocardial reperfusion have been studied for more than 40 years. It was long believed that only the ischaemic phase was harmful, through depletion of energy stores, ionic imbalance, and...
Cardiac transplantation has become limited by a critical shortage of suitable organs from brain-dead...
PURPOSE: With respect to organ shortage, Non heart Beating Donors (NHBD) are an alternative source o...
Introduction. Cardiovascular diseases are the number one cause of death globally contributing to 37%...
Communication suite à la séance du 31 mai 2011 "Optimiser la reprise fonctionnelle d'un greffon en a...
In cardiac transplantation, the transport time between harvest and recipient is limited by the viabi...
Heart transplant remains the gold standard of end-stage heart failure treatment. The number of heart...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
The traditional philosophy of ex vivo organ preservation has been to limit metabolic activity by sto...
Purpose of review The discrepancy between needs and availability of organs for heart transplantation...
Organ transplantation is one of the medical success stories of the 20th century. Transplantation is,...
Cardiac transplantation is the gold standard treatment for end-stage heart failure. Over the last 4...
Organ transplantation remains the treatment of last resort in case of failure of a vital organ (lung...
Organ transplantation is limited by ischemia/reperfusion injury inherent in the preservation period....
OBJECTIVES: Cardiac transplantation using hearts from donors after circulatory death (DCD) is critic...
Purpose of reviewThe discrepancy between needs and availability of organs for heart transplantation ...
Cardiac transplantation has become limited by a critical shortage of suitable organs from brain-dead...
PURPOSE: With respect to organ shortage, Non heart Beating Donors (NHBD) are an alternative source o...
Introduction. Cardiovascular diseases are the number one cause of death globally contributing to 37%...
Communication suite à la séance du 31 mai 2011 "Optimiser la reprise fonctionnelle d'un greffon en a...
In cardiac transplantation, the transport time between harvest and recipient is limited by the viabi...
Heart transplant remains the gold standard of end-stage heart failure treatment. The number of heart...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
The traditional philosophy of ex vivo organ preservation has been to limit metabolic activity by sto...
Purpose of review The discrepancy between needs and availability of organs for heart transplantation...
Organ transplantation is one of the medical success stories of the 20th century. Transplantation is,...
Cardiac transplantation is the gold standard treatment for end-stage heart failure. Over the last 4...
Organ transplantation remains the treatment of last resort in case of failure of a vital organ (lung...
Organ transplantation is limited by ischemia/reperfusion injury inherent in the preservation period....
OBJECTIVES: Cardiac transplantation using hearts from donors after circulatory death (DCD) is critic...
Purpose of reviewThe discrepancy between needs and availability of organs for heart transplantation ...
Cardiac transplantation has become limited by a critical shortage of suitable organs from brain-dead...
PURPOSE: With respect to organ shortage, Non heart Beating Donors (NHBD) are an alternative source o...
Introduction. Cardiovascular diseases are the number one cause of death globally contributing to 37%...